Fate Therapeutics to Present at World Muscle Society Congress
Published: Oct 03, 2013
SAN DIEGO, Oct. 2, 2013 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (Nasdaq:FATE), a biopharmaceutical company engaged in the discovery and development of adult stem cell modulators to treat orphan diseases, announced today that its Senior Vice President, Early Program Development, Dr. Peter Flynn, Ph.D., is scheduled to present at the 18th International World Muscle Society Congress (WMS) taking place in Asilomar, CA on October 1-5. Dr. Flynn will make his presentation during the Treatment Approaches for Muscular Dystrophy session at 11:00am PST on Friday, October 4.
Help employers find you! Check out all the jobs and post your resume.